Related references
Note: Only part of the references are listed.Use of nonaspirin nonsteroidal anti-inflammatory drugs and risk of head and neck cancer: A nationwide case-control study
Cecilie D. de la Cour et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
The Magic of Randomization versus the Myth of Real-World Evidence
Rory Collins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer
Matthew L. Hedberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Bayesian Networks for Risk Prediction Using Real-World Data: A Tool for Precision Medicine
Paul Arora et al.
VALUE IN HEALTH (2019)
Aspirin and nonsteroidal anti-inflammatory drug use and keratinocyte cancers: a large population-based cohort study of skin cancer in Australia
N. Pandeya et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Use of Natural Language Processing to Extract Clinical Cancer Phenotypes from Electronic Medical Records
Guergana K. Savova et al.
CANCER RESEARCH (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study
Rebecca D. Kehm et al.
BREAST CANCER RESEARCH (2019)
CLAMP - a toolkit for efficiently building customized clinical natural language processing pipelines
Ergin Soysal et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2018)
The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy
Jordan A. Krall et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Immortal Time Bias in Observational Studies of Time-to-Event Outcomes: Assessing Effects of Postmastectomy Radiation Therapy Using the National Cancer Database
Parul Agarwal et al.
CANCER CONTROL (2018)
Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician
Lawrence Blonde et al.
ADVANCES IN THERAPY (2018)
Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence
Theodore M. Brasky et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence
Theodore M. Brasky et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Reply to “Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non–Small Cell Lung Cancer: Methodological Issues”
Boris Sepesi et al.
Journal of Thoracic Oncology (2017)
The Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non-Small Cell Lung Cancer
Boris Sepesi et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Lung cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study
Thomas B. Richards et al.
CANCER (2017)
Ibuprofen and fatal lung cancer: A brief report of the prospective results from the Third National Health and Nutrition Examination Survey (NHANES III)
Marisa A. Bittoni et al.
MOLECULAR AND CLINICAL ONCOLOGY (2017)
Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the US Preventive Services Task Force
Jessica Chubak et al.
ANNALS OF INTERNAL MEDICINE (2016)
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
Kirsten Bibbins-Domingo
ANNALS OF INTERNAL MEDICINE (2016)
The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases
Hanna Dillekas et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Low-dose aspirin and survival from lung cancer: a population-based cohort study
Una C. Mc Menamin et al.
BMC CANCER (2015)
Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity
Bing Liu et al.
CANCER CELL INTERNATIONAL (2015)
Inflammation and cancer: advances and new agents
Shanthini M. Crusz et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Aspirin Use and Lung Cancer Risk: A Possible Relationship? Evidence from an Updated Meta-Analysis
Hai-yan Jiang et al.
PLOS ONE (2015)
NSAIDs Inhibit Tumorigenesis, but How?
Evrim Gurpinar et al.
CLINICAL CANCER RESEARCH (2014)
Cancer-related inflammation and treatment effectiveness
Connie I. Diakos et al.
LANCET ONCOLOGY (2014)
Mechanisms Governing Metastatic Dormancy and Reactivation
Filippo G. Giancotti
CELL (2013)
Reduction of Breast Cancer Relapses with Perioperative Non-Steroidal Anti-Inflammatory Drugs: New Findings and a Review
Michael Retsky et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
Annemijn M. Algra et al.
LANCET ONCOLOGY (2012)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
Biological Activity of Celecoxib in the Bronchial Epithelium of Current and Former Smokers
Edward S. Kim et al.
CANCER PREVENTION RESEARCH (2010)
Extracting medication information from clinical text
Oezlem Uzuner et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2010)
Immortal time bias in pharmacoepidemiology
Samy Suissa
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures
Romano Demicheli et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Models, mechanisms and clinical evidence for cancer dormancy
Julio A. Aguirre-Ghiso
NATURE REVIEWS CANCER (2007)
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2
Andrew T. Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Celecoxib for the prevention of colorectal adenomatous polyps
Nadir Arber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Celecoxib for the prevention of sporadic colorectal adenomas
Monica M. Bertagnolli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results
C. Mascaux et al.
BRITISH JOURNAL OF CANCER (2006)
Gender differences in non-small-cell lung cancer survival: An analysis of 4,618 patients diagnosed between 1997 and 2002
AL Visbal et al.
ANNALS OF THORACIC SURGERY (2004)
Smoking and lung cancer survival - The role of comorbidity and treatment
CM Tammemagi et al.
CHEST (2004)
Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: A systematic review and meta-analysis
WH Wang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer
RS Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Primary chemoprevention of familial adenomatous polyposis with sulindac
FM Giardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
